Search by
- Parties: The plaintiffs were Boehringer Ingelheim International GMBH and Boehringer Ingelheim Ltd (Canada). The defendant was Sandoz Canada Inc.
- Subject Matter: This action was brought under the Patented Medicines (NOC) Regulations.
- Date: The hearing was set on Feb. 20, 2024.
- Venue: This was a federal case before the Federal Court.
- Amount: No financial award was specified.
Download documents
Plaintiff
Defendant
Court
Federal CourtCase Number
T-1831-22Practice Area
Intellectual propertyAmount
Not specified/UnspecifiedWinner
Trial Start Date
08 September 2022